The obesity-linked peptide SP16 regulates adipocytes through GIP and insulin receptor
Thi My Hanh Ngo, Rakesh Santhanam, Daniel P. Teufel, Alec Dick, Daniel Lam, Holger Klein, Andreas‐David Brunner, Mafalda Maria Azevedo Pereira, Alexander Bartelt, Anton Pekcec, Maude Giroud
This study identifies SP16 as a novel GIP receptor agonist that promotes lipolysis and has metabolic benefits in diet-induced obese mice.
bioRxiv · Jun 17, 2025 · PreprintPharmacology & Toxicology